GATA3 and cancer: Consistent with its specific expression in luminal BC, GATA3 was identified as a highly selective dependency of luminal BC, along with ER and FOXA1, from systematic genome-wide RNAi- (33) or CRISPR-based (34) screens across hundreds of cancer cell lines.